Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma. (2014)
Attributed to:
BRIC: Packaging cell lines for inherently manufacturable viral vectors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2013.10.015
PubMed Identifier: 24262587
Publication URI: http://europepmc.org/abstract/MED/24262587
Type: Journal Article/Review
Volume: 50
Parent Publication: European journal of cancer (Oxford, England : 1990)
Issue: 3
ISSN: 0959-8049